Lung cancer treatment options

 Early detection of non-small cell lung cancer (the first stage Ⅰ and stage Ⅱ) in the treatment of surgical resection in order to mainly 

 Non-small cell lung cancer treatment strategy, IIIA period is divided into operable and inoperable, and patients before and after surgery, however, combined with chemotherapy (chemotherapy). 

 Advanced (Stage IIIB-IV) can take a single, double or triple the combined treatment approach, or to Platin (Pt)-based or non-Platin dual (Doublet) combined treatment approach. 

 For non-small cell lung cancer patients, according to ECOG criteria, to determine a patient's Performance status (capacity condition), clinical (or pathology) in phases to help physicians to determine what stage of treatment best suited to. 

  1. Based on ECOG criteria, judge the condition of a patient's capacity to determine the suitability of patients for treatment. To ECOG functional assessment score of 0 or 1 patients should be given aggressive treatment 

 2. Performance status for lung cancer and 2 patients, we must also consider additional questions to determine whether the treatment. 

 3. Performance status and lung cancer patients for 3-4, the only consider supporting the treatment of symptoms or the subject of the treatment (or a new generation of biological agents). 

 4. For patients subjected to chemotherapy or radiation therapy, doctors usually have their clinical experience and research papers based on other people, always hope for the sick is far greater than the benefits paid by patients for the treatment of risk and cost, under the premise to provide patients on the treatment of a more equitable option.